Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 16 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Phase III Adjuvant Chemotherapy with Intravesical ADR Alone and in Combination with Systemic cis-Platinum and 5-FU in Adult Patients with Superficial Bladder Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified								MSUCTC-8417 NCI-V85-0102

Last Modified: 2/1/1989


2.		Phase III Trial of ICS 205-930 vs a Metoclopramide-Containing Antiemetic Cocktail for the Prevention of Cisplatin-Induced Emesis in Patients with non-Small Cell Lung Cancer or Cancer of the Head and Neck (Summary Last Modified 02/89)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Closed				over 18								EORTC-08881

Last Modified: 5/1/1992


3.		Phase III Study of Sucralfate Suspension vs Maalox/Benadryl/Viscous Lidocaine Cocktail to Treat Therapy-Associated Mucositis in Cancer Patients (Summary Last Modified 05/92)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Closed				16 and over								ICC-88CCN1 NCI-P89-0013, NCI-C88-0010


4.		Phase II Chemotherapy with Neocarzinostatin for Advanced Metastatic Urothelial Bladder Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				no age specified								MSKCC-7757


5.		Phase II Chemotherapy with Rubidazone for Children with Refractory Acute Lymphoblastic or Acute Myelogenous Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				under 21				NCI				POG-7818 MDAR-313


6.		Phase II Chemotherapy with Neocarzinostatin for Acute Lymphocytic or Acute Nonlymphocytic Leukemia in Children

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and under				NCI				POG-7831 MDAR-319


7.		Phase II Chemotherapy with Rubidazone for Lymphoma in Relapsing Patients Previously Untreated with Anthracycline Derivatives

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified				NCI				SWOG-7734


8.		Phase II Chemotherapy with Bisantrene Hydrochloride for Refractory Gastric Adenocarcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified				NCI				SWOG-8120


9.		Phase II Chemotherapy with Bisantrene Hydrochloride for Refractory Hodgkin's Disease and non-Hodgkin's Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified				NCI				SWOG-8116

Last Modified: 10/16/2007


10.		Phase II Chemotherapy with Bisantrene Hydrochloride for Refractory Malignant Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified				NCI				SWOG-8118

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute